{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:27:11Z","timestamp":1770510431930,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ejpb.2013.02.015","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T06:31:42Z","timestamp":1363847502000},"page":"597-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"PA","title":["Drug\u2013membrane interaction studies applied to N\u2032-acetyl-rifabutin"],"prefix":"10.1016","volume":"85","author":[{"given":"Marina","family":"Pinheiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Ar\u00eade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o M.","family":"Caio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Moiteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"L\u00facio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2013.02.015_b0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2217\/nnm.11.122","article-title":"Liposomes as drug delivery systems for the treatment of TB","volume":"6","author":"Pinheiro","year":"2011","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.ejpb.2013.02.015_b0010","unstructured":"World Health Organization: Global Tuberculosis Control 2012 Report. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/75938\/1\/9789241564502_eng.pdf> (accessed 01.01.13)."},{"key":"10.1016\/j.ejpb.2013.02.015_b0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1465-9921-11-169","article-title":"New approaches in the diagnosis and treatment of latent tuberculosis infection","volume":"11","author":"Ahmad","year":"2010","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejpb.2013.02.015_b0020","doi-asserted-by":"crossref","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","article-title":"Tuberculosis and HIV co-infection","volume":"8","author":"Pawlowski","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejpb.2013.02.015_b0025","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"Gandhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2013.02.015_b0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bmc.2008.12.006","article-title":"Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis","volume":"17","author":"Figueiredo","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejpb.2013.02.015_b0035","first-page":"896","article-title":"Interplay of mycolic acids, antimycobacterial compounds and pulmonary surfactant membrane: a biophysical approach to disease","volume":"2013","author":"Pinheiro","year":"1828","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2013.02.015_b0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2174\/157340606778250199","article-title":"Interactions between oxicams and membrane bilayers: an explanation for their different COX selectivity","volume":"2","author":"Lucio","year":"2006","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejpb.2013.02.015_b0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.aca.2007.06.039","article-title":"Use of liposomes to evaluate the role of membrane interactions on antioxidant activity","volume":"597","author":"Lucio","year":"2007","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejpb.2013.02.015_b0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1574-6968.2006.00523.x","article-title":"Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase","volume":"266","author":"Paradis-Bleau","year":"2007","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejpb.2013.02.015_b0055","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbagen.2008.04.004","article-title":"Membrane interaction and perturbation mechanisms induced by two cationic cell penetrating peptides with distinct charge distribution","volume":"1780","author":"Alves","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2013.02.015_b0060","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.bbamem.2010.03.022","article-title":"Phosphatidyl alcohols: effect of head group size on domain forming properties and interactions with sterols","volume":"1798","author":"Jaikishan","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2013.02.015_b0065","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chemphyslip.2010.07.004","article-title":"Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects","volume":"163","author":"Brittes","year":"2010","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejpb.2013.02.015_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2012.12.005","article-title":"Biophysical characterization of the drugs\u2013membrane interaction. The case of propranolol and acebutolol","author":"Pereira-Leite","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2013.02.015_b0075","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/nprot.2010.137","article-title":"High-throughput microplate assay for the determination of drug partition coefficients","volume":"5","author":"Magalhaes","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejpb.2013.02.015_b0080","doi-asserted-by":"crossref","first-page":"12615","DOI":"10.1021\/jp206013z","article-title":"Lipid\u2013drug interaction: biophysical effects of tolmetin on membrane mimetic systems of different dimensionality","volume":"115","author":"Nunes","year":"2011","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejpb.2013.02.015_b0085","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/jps.21218","article-title":"Effect of nonsteroidal anti-inflammatory drugs on the cellular membrane fluidity","volume":"97","author":"Sousa","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2013.02.015_b0090","first-page":"877","article-title":"S4(13)-PV cell-penetrating peptide induces physical and morphological changes in membrane-mimetic lipid systems and cell membranes: implications for cell internalization","volume":"2012","author":"Cardoso","year":"1818","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2013.02.015_b0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0005-2736(94)90278-X","article-title":"Steady-state fluorescence studies on lipase\u2013vesicle interactions","volume":"1189","author":"Mosmuller","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2013.02.015_b0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.chemphyslip.2005.09.003","article-title":"Determination of phase transition temperatures of lipids by light scattering","volume":"139","author":"Michel","year":"2006","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejpb.2013.02.015_b0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0031-6997(24)01340-1","article-title":"Role of pharmacokinetics and metabolism in drug discovery and development","volume":"49","author":"Lin","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejpb.2013.02.015_b0110","series-title":"Tuberculosis: Pathogenesis, Protection, and Control","author":"Bloom","year":"1994"},{"key":"10.1016\/j.ejpb.2013.02.015_b0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-2952(99)00253-1","article-title":"Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs","volume":"59","author":"Barry Iii","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2013.02.015_b0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejps.2003.10.007","article-title":"Determination of lipid bilayer\/water partition coefficient of new phenothiazines using the second derivative of absorption spectra method","volume":"21","author":"Pola","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2013.02.015_b0125","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/jps.20351","article-title":"Interaction of clonixin with EPC liposomes used as membrane models","volume":"94","author":"Ferreira","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2013.02.015_b0130","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1016\/j.bpj.2009.02.012","article-title":"Monitoring biophysical properties of lipid membranes by environment-sensitive fluorescent probes","volume":"96","author":"Demchenko","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejpb.2013.02.015_b0135","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1529\/biophysj.104.055533","article-title":"Influence of DPH on the structure and dynamics of a DPPC bilayer","volume":"88","author":"Repakova","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejpb.2013.02.015_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(98)00081-9","article-title":"Fluorescence quenching data interpretation in biological systems. The use of microscopic models for data analysis and interpretation of complex systems","volume":"1373","author":"Castanho","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2013.02.015_b0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.colsurfb.2007.02.006","article-title":"New GHK hydrophobic derivatives: interaction with phospholipid bilayers","volume":"57","author":"Alminana","year":"2007","journal-title":"Colloids Surf. B: Biointerf."},{"key":"10.1016\/j.ejpb.2013.02.015_b0150","series-title":"Fluorescence Quenching: Theory and Applications. In the Principles of Fluorescence Spectroscopy","author":"Eftink","year":"2006"},{"key":"10.1016\/j.ejpb.2013.02.015_b0155","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1610-0387.2006.05948.x","article-title":"Dystrophic calcinosis cutis after subcutaneous administration of para-aminosalicylic acid for treatment of pulmonary tuberculosis","volume":"4","author":"Meissner","year":"2006","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.ejpb.2013.02.015_b0160","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.cplett.2009.02.047","article-title":"Effect of anti-inflammatory drugs in phosphatidylcholine membranes: a fluorescence and calorimetric study","volume":"471","author":"L\u00facio","year":"2009","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.ejpb.2013.02.015_b0165","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1021\/la201600y","article-title":"NSAIDs interactions with membranes: a biophysical approach","volume":"27","author":"Nunes","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2013.02.015_b0170","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1021\/la0008582","article-title":"Location and nature of the surface membrane binding site of ciprofloxacin: a fluorescence study","volume":"17","author":"V\u00e1zquez","year":"2001","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2013.02.015_b0175","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0006-3495(02)73922-2","article-title":"Rapid transbilayer movement of the fluorescent sterol dehydroergosterol in lipid membranes","volume":"83","author":"John","year":"2002","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejpb.2013.02.015_b0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-3084(03)00046-X","article-title":"DMPG gel\u2013fluid thermal transition monitored by a phospholipid spin labeled at the acyl chain end","volume":"124","author":"Riske","year":"2003","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejpb.2013.02.015_b0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature09657","article-title":"The challenge of new drug discovery for tuberculosis","volume":"469","author":"Koul","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2013.02.015_b0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0975-7406.76461","article-title":"Biomembrane models and drug\u2013biomembrane interaction studies: involvement in drug design and development","volume":"3","author":"Pignatello","year":"2011","journal-title":"J. Pharm. Bioallied Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641113000866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641113000866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T01:17:36Z","timestamp":1745975856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641113000866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0939641113000866"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.02.015","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug\u2013membrane interaction studies applied to N\u2032-acetyl-rifabutin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}